Beta Blocker Selection and Management in NSTEMI

Introduction to Beta Blocker Use

• The American College of Cardiology recommends that oral beta blockers should be initiated within the first 24 hours in NSTEMI patients without contraindications, with the specific agent chosen being less important than ensuring appropriate dosing and avoiding intravenous administration in hemodynamically unstable patients 1, 2

Route of Administration

• Oral beta blockers are the preferred initial route for most NSTEMI patients, as they reduce mortality without the increased risk of cardiogenic shock associated with intravenous administration 1, 2, 3
• Intravenous beta blockers may be considered only for specific indications such as hypertension in hemodynamically stable patients, but should be avoided in those with heart failure, low-output state, or increased shock risk 2, 4

Specific Beta Blocker Agents

• The American College of Cardiology/American Heart Association guidelines provide a table of acceptable beta blocker agents with their dosing, including metoprolol, atenolol, carvedilol, and bisoprolol 3
• Metoprolol may be administered at 50-200 mg twice daily orally, with intravenous administration reserved for specific cases 3
• Atenolol may be administered at 50-200 mg daily 3
• Bisoprolol may be administered at 10 mg daily 3
• Propranolol may be administered at 20-80 mg twice daily 3

Absolute Contraindications to Beta Blockers

• The American College of Cardiology recommends that beta blockers should not be administered in patients with signs of heart failure or pulmonary congestion, evidence of low-output state, high risk for cardiogenic shock, PR interval >0.24 seconds, second- or third-degree heart block, active asthma or reactive airway disease, or systolic blood pressure <100 mmHg 1, 2, 5

Practical Algorithm for Beta Blocker Initiation

• The American College of Cardiology recommends a step-wise approach to beta blocker initiation, including assessing for contraindications, initiating oral beta blockers within the first 24 hours, choosing a beta blocker agent, and starting with conservative dosing and titrating based on heart rate and blood pressure response 1, 2, 3, 5

Common Pitfalls to Avoid

• The American College of Cardiology recommends avoiding the routine use of intravenous beta blockers, delaying oral beta blocker initiation, and using immediate-release dihydropyridine calcium channel blockers as alternatives without adequate beta blockade first 3, 6